Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Antonio Vitale, Valeria Caggiano, Virginia Berlengiero, Maria Orsetta Perfetti, Jurgen Sota, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2023) Comparing biologic options for the management of Behcet’s disease-related uveitis. Expert Review of Clinical Immunology 19:3, pages 315-328.
Read now
Read now
Belén Atienza-Mateo, Diana Prieto-Peña, Esther F. Vicente-Rabaneda, Ricardo Blanco, Miguel A. González-Gay & Santos Castañeda. (2022) Utility of tocilizumab in autoimmune eye diseases. Expert Opinion on Biological Therapy 22:6, pages 789-799.
Read now
Read now
Arash Maleki, Sebastian Gomez, Soheila Asgari, Zoe Bosenberg, Ambika Manhapra, Marisa Walsh, Angelina Weng, Catherine Tsang, Celestine He, Stephen Damien Anesi & C. Stephen Foster. (2022) Diagnostic and Prognostic Roles of Serum Interleukin-6 Levels in Patients with Uveitis. Ocular Immunology and Inflammation 30:2, pages 457-462.
Read now
Read now
Emmett T. Cunningham, Alfredo Adán, Quan Dong Nguyen & Manfred Zierhut. (2021) Tocilizumab for the Treatment of Ocular Inflammatory Disease. Ocular Immunology and Inflammation 29:1, pages 2-5.
Read now
Read now
Aleksandra Radosavljevic, Mamta Agarwal, Bahram Bodaghi, Justine R. Smith & Manfred Zierhut. (2020) Medical Therapy of Uveitic Macular Edema: Biologic Agents. Ocular Immunology and Inflammation 28:8, pages 1239-1250.
Read now
Read now
Christina Fotiadou & Elizabeth Lazaridou. (2019) Psoriasis and uveitis: links and risks. Psoriasis: Targets and Therapy 9, pages 91-96.
Read now
Read now
Uwe Pleyer, Dominika Pohlmann, Esra Kardeş, Denis Poddubnyy & Judith Rademacher. (2019) Emerging drugs for the treatment of noninfectious uveitis. Expert Opinion on Emerging Drugs 24:3, pages 173-190.
Read now
Read now
Shinji Akioka. (2019) Interleukin-6 in juvenile idiopathic arthritis. Modern Rheumatology 29:2, pages 275-286.
Read now
Read now
Francesca Bartoli, Sangmee Bae, Laura Cometi, Marco Matucci Cerinic & Daniel E Furst. (2018) Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018. Expert Review of Clinical Immunology 14:7, pages 539-547.
Read now
Read now
Hassan Ghasemi. (2018) Roles of IL-6 in Ocular Inflammation: A Review. Ocular Immunology and Inflammation 26:1, pages 37-50.
Read now
Read now
Caiyun You, Haitham F Sahawneh, Lina Ma, Buraa Kubaisi, Alexander Schmidt & C Stephen Foster. (2017) A review and update on orphan drugs for the treatment of noninfectious uveitis. Clinical Ophthalmology 11, pages 257-265.
Read now
Read now
Arash Maleki, Halea Meese, Haitham Sahawneh & C. Stephen Foster. (2016) Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis. Expert Review of Clinical Immunology 12:7, pages 775-786.
Read now
Read now
Ivan Foeldvari. (2016) Managing uveitis in patients with juvenile idiopathic arthritis. Expert Opinion on Orphan Drugs 4:7, pages 741-745.
Read now
Read now
Khawla Abu Samra, Haitham Sahawneh & C. Stephen Foster. (2016) The role of biologic response modifiers in the management of juvenile idiopathic arthritis associated uveitis: a review. Expert Review of Ophthalmology 11:2, pages 155-163.
Read now
Read now
Articles from other publishers (31)
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, Mahsa Eshkevar Vakili, Paria Heydarinezhad, Narges Karami, Maryam Noroozi, Seppo Meri & Kurosh Kalantar. (2023) Immune responses in mildly versus critically ill COVID-19 patients. Frontiers in Immunology 14.
Crossref
Crossref
Mi Zhang & Xiaomin Zhang. (2023) T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches. International Immunopharmacology 114, pages 109565.
Crossref
Crossref
Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, Amirreza Allahgholipour, Seyed Rouhollah Miri, Terence T. Sio, Mark J. M. Sullman, Kristin Carson‐Chahhoud & Soheil Ebrahimpour. (2022) The role of cytokines and their antagonists in the treatment of COVID‐19 patients. Reviews in Medical Virology 33:1.
Crossref
Crossref
Maoyu Cai, Zunkai Xu, Xueyan Zhou, Liangpin Li, Xia Hua, Shutao Guo & Xiaoyong Yuan. (2022) Long-acting acid-sensitive ketal-linked dexamethasone microcrystals for treating experimental autoimmune uveitis. APL Bioengineering 6:4.
Crossref
Crossref
Caryn E. Plummer, Timothy Polk, Jatin Sharma, Sanghyo Sarah Bae, Olivia Barr, Amari Jones, Holly Kitchen, Michelle Wilhelmy, K. Devin, W. Clay Smith, Bryan D. Kolaczkowski & Joseph LarkinIIIIII. (2022) Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide. Scientific Reports 12:1.
Crossref
Crossref
Tiago Borges, Arsénio Barbosa & Sérgio Silva. 2022. Translational Autoimmunity. Translational Autoimmunity
83
114
.
Yanli Zou, Jing Jing Li, Wei Xue, Xiangbin Kong, Hucheng Duan, Yiqun Li & Lai Wei. (2021) Epigenetic Modifications and Therapy in Uveitis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yukio Takeshita, Susumu Fujikawa, Kenichi Serizawa, Miwako Fujisawa, Kinya Matsuo, Joe Nemoto, Fumitaka Shimizu, Yasuteru Sano, Haruna Tomizawa-Shinohara, Shota Miyake, Richard M. Ransohoff & Takashi Kanda. (2021) New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD. Neurology - Neuroimmunology Neuroinflammation 8:6, pages e1076.
Crossref
Crossref
Lan Yang, Xueru Xie, Zikun Tu, Jinrong Fu, Damo Xu & Yufeng Zhou. (2021) The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Keila Lopes Mendes, Deborah de Farias Lelis, Daniela Fernanda de Freitas, Luiz Henrique da Silveira, Alfredo Maurício Batista de Paula, André Luiz Sena Guimarães, Janaína Ribeiro Oliveira, Mariléia Chaves Andrade, Sérgio Avelino Mota Nobre & Sérgio Henrique Sousa Santos. (2021) Acute oral treatment with resveratrol and Lactococcus Lactis Subsp. Lactis decrease body weight and improve liver proinflammatory markers in C57BL/6 mice. Molecular Biology Reports 48:2, pages 1725-1734.
Crossref
Crossref
Rohan Bir Singh, Shruti Sinha, Chhavi Saini, Elsayed Elbasiony, Sahil Thakur & Aniruddha Agarwal. (2020) Recent advances in the management of non-infectious posterior uveitis. International Ophthalmology 40:11, pages 3187-3207.
Crossref
Crossref
Yankai Wei, Na Li, Lu Zhao, Chao Yang, Binyun Ma, Xiaorong Li, Ruihua Wei & Hong Nian. (2020) MicroRNAs and Autoimmune-Mediated Eye Diseases. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Anja Schnabel, Elisabeth Unger, Normi Brück, Reinhard Berner, Ursula Range, Annette Holl-Wieden, Henner Morbach, Anna Leszczynska, Viktoria Bau & Christian M. Hedrich. (2020) High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis. Clinical Immunology 211, pages 108327.
Crossref
Crossref
Nadiya B. Kuryltsiv & Kateryna M. Halei. (2019) THE ROLE OF INTERLEUKINS AND THEIR INHIBITORS IN THE DEVELOPMENT OF AUTOIMMUNE UVEITIS. Wiadomości Lekarskie 72:4, pages 716-722.
Crossref
Crossref
Nuria Vegas-Revenga, Vanesa Calvo-Río, Marina Mesquida, Alfredo Adán, María Victoria Hernández, Emma Beltrán, Elia Valls Pascual, David Díaz-Valle, Gisela Díaz-Cordovés, Marisa Hernandez-Garfella, Lucía Martínez-Costa, Inmaculada Calvo, Antonio Atanes, Luis F. Linares, Consuelo Modesto, Carmen González-Vela, Rosalia Demetrio-Pablo, Elena Aurrecoechea, Miguel Cordero, Lucía C. Domínguez-Casas, Belén Atienza-Mateo, José Luis Martín-Varillas, Javier Loricera, Natalia Palmou-Fontana, José L. Hernández, Miguel A. González-Gay & Ricardo Blanco. (2019) Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients. American Journal of Ophthalmology 200, pages 85-94.
Crossref
Crossref
Shilpa Kodati & Christina Y. Weng. (2019) Current and Emerging Pharmaceutical Therapies for Noninfectious Uveitis. International Ophthalmology Clinics 59:1, pages 111-126.
Crossref
Crossref
Marina Mesquida, Victor Llorenç & Alfredo Adán. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis
95
112
.
Justine R. Smith. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis
179
188
.
Yanxia Ding, Chaoran Li, Jinjing Liu, Xin Yu, Yining Wang, Jing Shi, Lu Li, Jiaxin Zhou, Li Wang, Hua Chen, Yan Zhao & Wenjie Zheng. (2018) Tocilizumab in the treatment of severe and/or refractory vasculo-Behçet’s disease: a single-centre experience in China. Rheumatology.
Crossref
Crossref
M. O'Rourke, U. Fearon, C.M. Sweeney, S.A. Basdeo, J.M. Fletcher, C.C. Murphy & M. Canavan. (2018) The pathogenic role of dendritic cells in non-infectious anterior uveitis. Experimental Eye Research 173, pages 121-128.
Crossref
Crossref
Marina MesquidaBlanca MolinsVictor LlorençMaría V. Hernández, Gerard EspinosaMaite Sainz de la MazaAlfredo Adán. (2018) TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Retina 38:7, pages 1361-1370.
Crossref
Crossref
Srilakshmi M. Sharma, Dun Jack Fu & Kanmin Xue. (2017) A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis. Ophthalmology and Therapy 7:1, pages 1-17.
Crossref
Crossref
Jessica E. Weinstein & Kathryn L. Pepple. (2018) Cytokines in uveitis. Current Opinion in Ophthalmology 29:3, pages 267-274.
Crossref
Crossref
Belén Atienza-Mateo, Vanesa Calvo-Río, Emma Beltrán, Lucía Martínez-Costa, Elia Valls-Pascual, Marisa Hernández-Garfella, Antonio Atanes, Miguel Cordero-Coma, Joan Miquel Nolla, Carmen Carrasco-Cubero, Javier Loricera, María C González-Vela, Nuria Vegas-Revenga, Carlos Fernández-Díaz, Rosalía Demetrio-Pablo, Lucía C Domínguez-Casas, José Luis Martín-Varillas, Natalia Palmou-Fontana, José L Hernández, Miguel Á González-Gay & Ricardo Blanco. (2018) Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study. Rheumatology 57:5, pages 856-864.
Crossref
Crossref
Feng Zhang, Dejun Fan & Xiao‑Neng Mo. (2018) Prohibitin and the extracellular matrix are upregulated in murine alveolar epithelial cells with LPS‑induced acute injury. Molecular Medicine Reports.
Crossref
Crossref
Radgonde Amer, Hilal Nalcı & Nilüfer Yalçındağ. (2017) Exudative retinal detachment. Survey of Ophthalmology 62:6, pages 723-769.
Crossref
Crossref
Yasir Jamal Sepah, Mohammad Ali Sadiq, David S. Chu, Mark Dacey, Ron Gallemore, Pouya Dayani, Mostafa Hanout, Muhammad Hassan, Rubbia Afridi, Aniruddha Agarwal, Muhammad Sohail Halim, Diana V. Do & Quan Dong Nguyen. (2017) Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis. American Journal of Ophthalmology 183, pages 71-80.
Crossref
Crossref
Marina Mesquida, Blanca Molins, Víctor Llorenç, Maite Sáinz de la Maza & Alfredo Adán. (2017) Targeting interleukin-6 in autoimmune uveitis. Autoimmunity Reviews 16:10, pages 1079-1089.
Crossref
Crossref
Arjun B. Sood & Sheila T. Angeles-Han. (2017) An Update on Treatment of Pediatric Chronic Non-infectious Uveitis. Current Treatment Options in Rheumatology 3:1, pages 1-16.
Crossref
Crossref
T. A. Danilova, G. A. Danilina, A. A. Adzhieva, A. G. Minko & V. G. Zhukhovitskii. (2016) Interleukin-6 in Sera of Mice Inoculated with Group A Streptococcus and Cultural Supernatants. Bulletin of Experimental Biology and Medicine 161:6, pages 797-800.
Crossref
Crossref
Jared E. Knickelbein, Karen R. Armbrust, Meredith Kim, H. Nida Sen & Robert B. Nussenblatt. 2017. Pharmacologic Therapy of Ocular Disease. Pharmacologic Therapy of Ocular Disease
231
268
.